Close
New

Medscape is available in 5 Language Editions – Choose your Edition here.

 

nitroprusside sodium (Rx)Brand and Other Names:Nipride, Nitropress, more...Sodium Nitroprusside

 
 
 

Dosing & Uses

AdultPediatricGeriatric

Dosage Forms & Strengths

injectable solution

  • 25mg/mL
more...

Blood Pressure Control

Indicated for the immediate reduction of blood pressure in hypertensive crises

Indicated for producing controlled hypotension to reduce bleeding during surgery

Also indicated for treatment of acute congestive heart failure

Initial: 0.25-0.3 mcg/kg/min IV infusion; may increase by 0.5 mcg/kg/min every few minutes to achieve desired results  

Usual range: 3-4 mcg/kg/min IV infusion, not to exceed 10 mcg/kg/min

Cerebral Vasospasm (Orphan)

Treatment and prevention of cerebral vasospasm following subarachnoid hemorrhage

Orphan indication sponsor

  • Jeffrey Evan Thomas, MD; Thomas Jefferson University and Wills Neurosensory, 834 Walnut Street, Suite 650; Philadelphia, PA 19107-5102

Renal Impairment

Use in patients with renal failure may cause accumulation of thiocyanate and subsequent toxicity

Hepatic Impairment

Use caution due to risk of cyanide toxicity

Other Indications & Uses

Off-label: MI (with dopamine); left ventricular failure (with O2, morphine, loop diuretic)

Dosage Forms & Strengths

injectable solution

  • 25mg/mL
more...

Other Indications & Uses

Same as adult, no more than 10 mcg/kg/min (6 mcg/kg/min in neonates) 

Blood pressure control

Indicated for the immediate reduction of blood pressure in hypertensive crises  

Indicated for producing controlled hypotension to reduce bleeding during surgery  

Also indicated for treatment of acute congestive heart failure

Initial: 0.25-0.3 mcg/kg/min IV infusion; may increase by 0.5 mcg/kg/min every few minutes to achieve desired results

Usual range: 3-4 mcg/kg/min IV infusion, not to exceed 10 mcg/kg/min 

Next

Interactions

Interaction Checker

nitroprusside sodium and

No Results

     
     activity indicator 
    No Interactions Found
    Interactions Found

    Contraindicated

      Serious - Use Alternative

        Significant - Monitor Closely

          Minor

            Sort by :  
             activity indicator 
            Previous
            Next

            Adverse Effects

            Frequency Not Defined

            Common

            • Bradyarrhythmia, hypotension, palpitations, tachyarrhythmia
            • Apprehension, restlessness, confusion, dizziness, headache, somnolence
            • Rash, sweating
            • Thyroid suppression
            • Injection site irritation
            • Muscle twitch
            • Oliguria, renal azotemia

            Serious

            • Cardiac dysrhythmia, hemorrhage, decreased platelet aggregation, excessive hypotensive response
            • Raised intracranial pressure
            • Metabolic acidosis
            • Bowel obstruction
            • Methemoglobinemia
            • Cyanide poisoning
            • Thiocyanate toxicity
            Previous
            Next

            Warnings

            Black Box Warnings

            Not suitable for direct injection; requires dilution prior to infusion

            Hypotension may occur, leading to irreversible ischemic injury or death; requires appropriate monitoring equipment and experienced personnel

            Cyanide toxicity may occur because of accumulation of cyanide ion

            Contraindications

            Hypersensitivity

            Compensatory HTN (eg, arteriovenous shunt or aortic coarctation); (for controlled hypotension): inadequate cerebral circulation

            Certain rare conditions, eg, congenital optic atrophy, tobacco amblyopia

            Treatment of acute CHF associated with reduced peripheral vascular resistance

            Not for use in emergency surgery in very ill patients

            Cautions

            Head trauma, increases ICP, hyponatremia, hypothyroidism, severe hepatic or renal impairment, elderly

            Cyanide toxicity can develop within 1 hr with infusions >10 mcg/kg/min

            • Check thiocyanate levels, monitor pulse oximeter

            Thiocyanate clearance decreased with renal failure

            Protect from light, do not use if discolored

            Previous
            Next

            Pregnancy & Lactation

            Pregnancy Category: C

            Lactation: not known if distributed into milk

            Pregnancy Categories

            A:Generally acceptable. Controlled studies in pregnant women show no evidence of fetal risk.

            B:May be acceptable. Either animal studies show no risk but human studies not available or animal studies showed minor risks and human studies done and showed no risk.

            C:Use with caution if benefits outweigh risks. Animal studies show risk and human studies not available or neither animal nor human studies done.

            D:Use in LIFE-THREATENING emergencies when no safer drug available. Positive evidence of human fetal risk.

            X:Do not use in pregnancy. Risks involved outweigh potential benefits. Safer alternatives exist.

            NA:Information not available.

            more...
            Previous
            Next

            Pharmacology

            Mechanism of Action

            Relaxes vascular smooth muscle to reduce afterload & preload by producing NO

            Also dilates coronary arteries

            Pharmacokinetics

            Half-Life: parent drug: 2 min, metabolite (thiocyanate): 3 days, longer in patients with impaired renal function or hyponatremia

            Onset of action: <2 min

            Duration: 1-10 min

            Metabolism: in blood (100%); ferrous ion in nitroprusside molecule reacts rapidly with sulfhydryl compounds in RBCs which results in cyanide release, which is then metabolized in liver and kidney by rhodanese to thiocyanate

            Metabolites: Thiocyanate (inactive)

            Excretion: Mainly in urine, excreted entirely as metabolites, principally thiocyanate

            Dialyzable: Yes (HD)

            Previous
            Next

            Administration

            IV Incompatibilities

            Additive: atracurium

            Y-site: amiodarone(?), cisatracurium (at 2+ mg/mL cisatra, may be compatible at 0.1 mg/mL cisatra), haloperidol (at 5 mg/mL halo, may be compatible at 0.5 mg/mL halo), levofloxacin, propafenone(?)

            IV Compatibilities

            Solution: D5W, LR, NS (when not exposed to bright light)

            Additive: cimetidine, enalaprilat, ranitidine, verapamil

            Syringe: caffeine, heparin

            Y-site: alprostadil, atracurium, bivalirudin, CaCl2, dexmedetomidine, diltiazem, dobutamine, dopamine, enalaprilat, esmolol, famotidine, furosemide, heparin, hetastarch, inamrinone, insulin, isoproterenol, labetalol, lidocaine, MgSO4, midazolam, morphine sulfate, nicardipine, nitroglycerin, pancuronium, KCl, potassium phosphates, procainamide, propofol, tacrolimus, theophylline, vecuronium

            IV Preparation

            Reconstitute 50 mg vial in 2-3 mL D5W or SWI (NOT BWI, increases decomposition rate)

            Dilute reconstituted soln (or 25 mg/mL vial, contains 2 mL) with 250-1000 mL D5W (final conc 50-200 mcg/mL)

            Wrap container in aluminum foil

            Solution should be reddish-brown; discard if blue

            Do not freeze

            Use within 24 hr

            IV Administration

            Infusion pump required; not for direct injection

            Previous
            Next

            Images

            Previous
            Next

            Formulary

            FormularyPatient Discounts

            To view formulary information first create a list of plans. Your list will be saved and can be edited at any time.

            Adding plans allows you to:

            • View the formulary and any restrictions for each plan.
            • Manage and view all your plans together – even plans in different states.
            • Compare formulary status to other drugs in the same class.
            • Access your plan list on any device – mobile or desktop.

            The above information is provided for general informational and educational purposes only. Individual plans may vary and formulary information changes. Contact the applicable plan provider for the most current information.

            Tier Description
            1 This drug is available at the lowest co-pay. Most commonly, these are generic drugs.
            2 This drug is available at a middle level co-pay. Most commonly, these are "preferred" (on formulary) brand drugs.
            3 This drug is available at a higher level co-pay. Most commonly, these are "non-preferred" brand drugs.
            4 This drug is available at a higher level co-pay. Most commonly, these are "non-preferred" brand drugs or specialty prescription products.
            5 This drug is available at a higher level co-pay. Most commonly, these are "non-preferred" brand drugs or specialty prescription products.
            6 This drug is available at a higher level co-pay. Most commonly, these are "non-preferred" brand drugs or specialty prescription products.
            NC NOT COVERED – Drugs that are not covered by the plan.
            Code Definition
            PA Prior Authorization
            Drugs that require prior authorization. This restriction requires that specific clinical criteria be met prior to the approval of the prescription.
            QL Quantity Limits
            Drugs that have quantity limits associated with each prescription. This restriction typically limits the quantity of the drug that will be covered.
            ST Step Therapy
            Drugs that have step therapy associated with each prescription. This restriction typically requires that certain criteria be met prior to approval for the prescription.
            OR Other Restrictions
            Drugs that have restrictions other than prior authorization, quantity limits, and step therapy associated with each prescription.
            Add or Remove Plans
            Plans for
            Select State:
            Non-Medicare PlansMedicare Plans

            Select a box to add or remove a plan.

            Select a class to view formulary status for similar drugs

            Additional Offers
            Email to Patient

            From:

            To:

            The recipient will receive more details and instructions to access this offer.

            By clicking send, you acknowledge that you have permission to email the recipient with this information.

            Email Forms to Patient

            From:

            To:

            The recipient will receive more details and instructions to access this offer.

            By clicking send, you acknowledge that you have permission to email the recipient with this information.

            Previous
             
             
             
            All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.